Across rheumatic diseases

The mSQUASH is a feasible and valid measurement tool to uniformly assess daily physical activity in patients with rheumatic diseases

RMD OpenPublished Validation study

Authors' conclusion

The mSQUASH showed good linguistic and face validity according to field testing in different rheumatic diseases. Clinical validation confirmed good construct validity, test-retest reliability and responsiveness in patients with axSpA

Study context

Population
Patients with rheumatic diseases: Axial spondyloarthritis (axSpA), SjD, SLE and GCA/PMR (field testing); patients with axSpA (clinical validation)interviews: axSpA 13, SjD 10, SLE 10, GCA/PMR 10
Outcome
Linguistic and face validity (field testing); construct validity, test-retest reliability and responsiveness of the English mSQUASH (clinical validation in axSpA)
Methodological detailstranslation and cross-cultural adaptation (forward-backward Beaton protocol), semistructured interviews, clinical validation
  • Translation and cross-cultural adaptation (forward-backward Beaton protocol)
  • Semistructured interviews
  • Clinical validation

Performance

As reported in the abstract

Measurement properties of the English mSQUASH in axSpA
Construct validity (n=95): Spearman correlation with ASDAS
ρ=−0.31
Construct validity: Spearman correlation with BASFI
ρ=−0.37
Construct validity: Spearman correlation with ASAS Health Index
ρ=−0.30
Test-retest reliability (n=82), intraclass correlation coefficients (ICC)
0.87
Responsiveness (n=80), standardised response means (SRM), improved
0.72
Responsiveness, SRM, stable
0.06
Responsiveness, SRM, worsened
−0.74

Original publication

The mSQUASH is a feasible and valid measurement tool to uniformly assess daily physical activity in patients with rheumatic diseases. RMD Open. Published 23 October 2024. doi:10.1136/rmdopen-2024-004696

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.